{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:28:44Z","timestamp":1791250124703,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1684\/bdc.2014.1977","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:02:13Z","timestamp":1565726533000},"page":"1109-1113","source":"Crossref","is-referenced-by-count":10,"title":["FR\u03b1 : une cible pour la th\u00e9rapie photodynamique prophylactique des m\u00e9tastases p\u00e9riton\u00e9ales ovariennes ?"],"prefix":"10.1016","volume":"101","author":[{"given":"Henri","family":"Aza\u00efs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Moussaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Khodja Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Bassil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacim","family":"Betrouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Frochot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Collinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Mordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2014.1977_bib0005","first-page":"CD008765","article-title":"Surgical cytoreduction for recurrent epithelial ovarian cancer","volume":"2","author":"Al Rawahi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1684\/bdc.2014.1977_bib0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2006.07.004","article-title":"\u201cOptimal\u201d cytoreduction for advanced epithelial ovarian cancer: a commentary","volume":"103","author":"Eisenkop","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"Supplement 3","key":"10.1684\/bdc.2014.1977_bib0015","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0959-8049(11)70152-6","article-title":"Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer","volume":"47","author":"Vergote","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2014.1977_bib0020","doi-asserted-by":"crossref","unstructured":"Elias D, Go\u00e9r\u00e9 D, Dumont F, et al. Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. Eur J Cancer 2014 ; 50 : 332-40.","DOI":"10.1016\/j.ejca.2013.09.024"},{"key":"10.1684\/bdc.2014.1977_bib0025","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1684\/bdc.2014.1977_bib0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pdpdt.2007.07.003","article-title":"Evaluation of ALA-PDT of ovarian cancer in the Fisher 344 rat tumor model","volume":"4","author":"Ascencio","year":"2007","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1684\/bdc.2014.1977_bib0035","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.bmc.2005.02.025","article-title":"Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy","volume":"13","author":"Schneider","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1684\/bdc.2014.1977_bib0040","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm800125a","article-title":"Improvement of meta-tetra (hydroxyphenyl) chlorin-like photosensitizer selectivity with folate-based targeted delivery. Synthesis and in vivo delivery studies","volume":"51","author":"Gravier","year":"2008","journal-title":"J Med Chem"},{"key":"10.1684\/bdc.2014.1977_bib0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1039\/c3pp25384h","article-title":"Folate-targeted PEGylated liposomes improve the selectivity of PDT with meta-tetra(hydroxyphenyl)chlorin (m-THPC)","volume":"12","author":"Moret","year":"2013","journal-title":"Photochem Photobiol Sci"},{"key":"10.1684\/bdc.2014.1977_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jphotobiol.2013.06.008","article-title":"A novel chlorin-PEG-folate conjugate with higher water solubility, lower cytotoxicity, better tumor targeting and photodynamic activity","volume":"127C","author":"Li","year":"2013","journal-title":"J Photochem Photobiol B"},{"key":"10.1684\/bdc.2014.1977_bib0055","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nm.2472","article-title":"Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-\u03b1 targeting: first in-human results","volume":"17","author":"Van Dam","year":"2011","journal-title":"Nat Med"},{"key":"10.1684\/bdc.2014.1977_bib0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jn\/130.2.129","article-title":"Folate and carcinogenesis: an integrated scheme","volume":"130","author":"Choi","year":"2000","journal-title":"J Nutr"},{"key":"10.1684\/bdc.2014.1977_bib0065","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2013.03.024","article-title":"Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy","volume":"130","author":"Despierre","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1977_bib0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.nu.16.070196.002441","article-title":"Folate receptors","volume":"16","author":"Antony","year":"1996","journal-title":"Annu Rev Nutr"},{"key":"10.1684\/bdc.2014.1977_bib0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1359-6446(00)01594-4","article-title":"Folate-mediated targeting: from diagnostics to drug and gene delivery","volume":"6","author":"Leamon","year":"2001","journal-title":"Drug Discov Today"},{"key":"10.1684\/bdc.2014.1977_bib0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-409X(99)00062-9","article-title":"Targeted drug delivery via the folate receptor","volume":"41","author":"Sudimack","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1684\/bdc.2014.1977_bib0085","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","article-title":"Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay","volume":"338","author":"Parker","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1684\/bdc.2014.1977_bib0090","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ygyno.2007.11.020","article-title":"Folate receptor alpha as a tumor target in epithelial ovarian cancer","volume":"108","author":"Kalli","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"6A","key":"10.1684\/bdc.2014.1977_bib0095","first-page":"3567","article-title":"Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue","volume":"28","author":"Markert","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1684\/bdc.2014.1977_bib0100","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","article-title":"Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy","volume":"56","author":"Elnakat","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1684\/bdc.2014.1977_bib0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/PGP.0b013e3182774562","article-title":"Expression of folate receptor-\u03b1 (FRA) in gynecologic malignancies and its relationship to the tumor type","volume":"32","author":"O'Shannessy","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"10.1684\/bdc.2014.1977_bib0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13402-011-0052-6","article-title":"The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer","volume":"35","author":"Crane","year":"2011","journal-title":"Cell Oncol"},{"key":"10.1684\/bdc.2014.1977_bib0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.molonc.2011.11.010","article-title":"Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response","volume":"6","author":"Chen","year":"2012","journal-title":"Mol Oncol"},{"key":"10.1684\/bdc.2014.1977_bib0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F","article-title":"Overexpression of folate binding protein in ovarian cancers","volume":"74","author":"Toffoli","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1684\/bdc.2014.1977_bib0125","doi-asserted-by":"crossref","first-page":"e47201","DOI":"10.1371\/journal.pone.0047201","article-title":"Paradoxical impact of two folate receptors, FR\u03b1 and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome","volume":"7","author":"Siu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1684\/bdc.2014.1977_bib0130","first-page":"5791","article-title":"Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH\/3T3 cells increases cell growth in vitro and in vivo","volume":"53","author":"Bottero","year":"1993","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2014.1977_bib0135","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0046-8177(97)90007-1","article-title":"Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases","volume":"28","author":"Dara\u00ef","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1684\/bdc.2014.1977_bib0140","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","article-title":"Loss of E-Cadherin promotes ovarian cancer metastasis via \u03b15-integrin, which is a therapeutic target","volume":"68","author":"Sawada","year":"2008","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2014.1977_bib0145","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/jpet.108.143206","article-title":"Impact of high and low folate diets on tissue folate receptor levels and antitumor responses toward folate-drug conjugates","volume":"327","author":"Leamon","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1684\/bdc.2014.1977_bib0150","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1073\/pnas.88.13.5572","article-title":"Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis","volume":"88","author":"Leamon","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"10.1684\/bdc.2014.1977_bib0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10147-012-0459-8","article-title":"Clinical trials and future potential of targeted therapy for ovarian cancer","volume":"17","author":"Itamochi","year":"2012","journal-title":"Int J Clin Oncol"},{"key":"10.1684\/bdc.2014.1977_bib0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.21712","article-title":"The role of folate receptor \u03b1 in cancer development, progression and treatment: cause, consequence or innocent bystander?","volume":"119","author":"Kelemen","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1684\/bdc.2014.1977_bib0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2310\/7290.2011.00004","article-title":"Intraoperative imaging in ovarian cancer: fact or fiction?","volume":"10","author":"Crane","year":"2011","journal-title":"Mol Imaging"},{"key":"10.1684\/bdc.2014.1977_bib0170","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1016\/j.biomaterials.2011.07.067","article-title":"Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis","volume":"32","author":"Werner","year":"2011","journal-title":"Biomaterials"},{"key":"10.1684\/bdc.2014.1977_bib0175","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/sj.gt.3301962","article-title":"Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies","volume":"10","author":"Figini","year":"2003","journal-title":"Gene Ther"},{"key":"10.1684\/bdc.2014.1977_bib0180","unstructured":"Ebel W, Routhier EL, Foley B, et al. Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Cancer Immun [Internet] 2007 ; 7. Available from:\/pmc\/articles\/PMC2935753\/?report=Abstract. [cited 2013 Aug 5]"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115303076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115303076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:28:12Z","timestamp":1602491292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115303076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0007455115303076"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2014.1977","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}